US court finds ‘robust’ anti-fraud safeguards in Novartis settlement
By Mike Scarcella, Reuters — July 26, 2024
A federal magistrate judge praised the settlement administration in the $30 million Novartis antitrust case, commending Angeion Group for its diligence and sophisticated fraud prevention.
U.S. Magistrate Judge Stewart Aaron concluded that Angeion’s claims process “has integrity and has been carried out in a diligent and thorough manner.” His report highlighted Angeion’s advanced fraud detection program — incorporating artificial intelligence, behavioral analysis, IP monitoring, and email verification — as both prudent and necessary in identifying and preventing tens of thousands of fraudulent or duplicative claims.
The court further recognized Angeion’s commitment to ensuring legitimate claimants received their payments, recommending reminder notices for class members with uncashed checks.
This independent validation underscores Angeion’s industry-leading safeguards, combining cutting-edge technology with rigorous process management to protect the fairness of complex class action settlements.
Case Works and Donlin Recano & Co. are now Angeion Group